SHP2-IN-35

SHP2-IN-35 is a potent SHP2 inhibitor with antiproliferative effects in cancer cell lines including RKO, SW480, and CT26. It modulates the PI3K/Akt pathway, induces autophagy, and alters cytokine expression within the tumor microenvironment, making it a valuable tool for oncology and signaling research in vitro.